Literature DB >> 12189723

Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.

David B Volkin1, Gautam Sanyal, Carl J Burke, C Russell Middaugh.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12189723     DOI： 10.1007/978-1-4615-0549-5_1

Source DB:  PubMed          Journal:  Pharm Biotechnol        ISSN： 1078-0467


× No keyword cloud information.
  9 in total

1.  FTIR and nDSC as analytical tools for high-concentration protein formulations.

Authors:  Susanne Matheus; Wolfgang Friess; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

2.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 3.  Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Authors:  Rajan Swami; Aliasgar Shahiwala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-14       Impact factor: 2.441

4.  A critical evaluation of Tm(FTIR) measurements of high-concentration IgG1 antibody formulations as a formulation development tool.

Authors:  Susanne Matheus; Hanns-Christian Mahler; Wolfgang Friess
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

Review 5.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

6.  Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.

Authors:  Tia Estey; Christina Vessely; Theodore W Randolph; Ian Henderson; Latoya Jones Braun; Rajiv Nayar; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

7.  Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.

Authors:  Alexandra B Sassi; Katherine E Bunge; Brian L Hood; Thomas P Conrads; Alexander M Cole; Phalguni Gupta; Lisa C Rohan
Journal:  AIDS Res Ther       Date:  2011-07-29       Impact factor: 2.250

8.  Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Authors:  Inês Bártolo; Ana Rita Diniz; Pedro Borrego; João Pedro Ferreira; Maria Rosário Bronze; Helena Barroso; Rui Pinto; Carlos Cardoso; João F Pinto; Rafael Ceña Diaz; Pilar Garcia Broncano; Maria Angel Muñoz-Fernández; Nuno Taveira
Journal:  PLoS One       Date:  2018-04-18       Impact factor: 3.240

9.  A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.

Authors:  Wen-Chun Lin; Yun-Ru Chen; Chi-Mu Chuang; Jyh-Yih Chen
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 6.064
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.